Keywords: healthy, first-half, earnings, growth, germany, schwarz, pharma
Healthy first-half earnings growth for Germany's Schwarz Pharma
Article | 06 August 2001
German drugmaker Schwarz Pharma has posted a 4.5% increase in sales forthe first half of 2001 to 382.1 million euros ($334.1 million), while gross ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
